Details.
Provides Combivir, Cabenuva, Dovato, Epivir, Epzicom, Juluca, Lexiva, Prezcobix, Rukobia, Selzentry, Tivicay, Tivicay PD, Triumeq, Triumeq PD, Trizivir, Viracept, and Ziagen for eligible individuals. Financial eligibility is 500% FPL. Some listed products stopped accepting new applications or are scheduled for discontinuation as described in the program information.